Schroder Investment Management Group’s Harmony Biosciences HRMY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-72,678	Closed	-$2.74M	–	1223
2025 Q4	$2.74M	Buy	72,678 +16,532	+29%	+$544K	﹤0.01%	840
2025 Q3	$1.55M	Sell	56,146 -4,418	-7%	-$152K	﹤0.01%	971
2025 Q2	$1.91M	Sell	60,564 -119	-0.2%	-$3.83K	﹤0.01%	917
2025 Q1	$2.01M	Buy	+60,683	New	+$2.18M	﹤0.01%	902
2024 Q4	–	Sell	-29,579	Closed	-$1.16M	–	1218
2024 Q3	$1.16M	Hold	29,579	–	–	﹤0.01%	1012
2024 Q2	$892K	Sell	29,579 -147,875	-83%	-$4.45M	﹤0.01%	1048
2024 Q1	$5.96M	Sell	177,454 -50,046	-22%	-$1.61M	0.01%	750
2023 Q4	$7.35M	Buy	+227,500	New	+$6.35M	0.01%	690
2023 Q3	–	Sell	-106,527	Closed	-$3.75M	–	1217
2023 Q2	$3.75M	Sell	106,527 -151,861	-59%	-$5.24M	0.01%	836
2023 Q1	$8.44M	Buy	258,388 +117,404	+83%	+$5.35M	0.01%	665
2022 Q4	$7.77M	Buy	140,984 +74,422	+112%	+$4.09M	0.01%	680
2022 Q3	$2.95M	Buy	+66,562	New	+$3.25M	﹤0.01%	871
2022 Q1	–	Sell	-33,469	Closed	-$1.43M	–	1460
2021 Q4	$1.43M	Buy	+33,469	New	+$1.33M	﹤0.01%	983